Medicare Enrolled

Dr. Sujata Lalla-Reddy, M.D.

Infectious Disease · Fountain Valley, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
9940 TALBERT AVE STE 101, Fountain Valley, CA 92708
9494781894
In practice since 2006 (19 years)
NPI: 1891711909 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lalla-Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lalla-Reddy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lalla-Reddy

Dr. Sujata Lalla-Reddy is an infectious disease specialist in Fountain Valley, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lalla-Reddy performed 5,027 Medicare services across 1,603 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lalla-Reddy received a total of $56,191 from 52 pharmaceutical and/or device companies across 605 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lalla-Reddy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 5% volume in CA $56,191 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,027
Medicare services
Top 5% in CA for infectious disease
1,603
Unique beneficiaries
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~265 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
2,508 $99 $486
Nursing facility visit, moderate complexity
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes.
1,047 $89 $285
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
652 $145 $450
Hospital discharge management, 30+ min
This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge.
437 $96 $425
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
225 $176 $510
Initial nursing facility care, high complexity
An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes.
97 $154 $450
Transitional care management, high complexity
Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem.
26 $160 $400
Home health plan of care certification
Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians.
21 $46 $195
Nursing facility discharge management, more than 30 minutes
This service involves care coordination and management activities performed by a healthcare professional to prepare a patient for discharge from a nursing facility. It requires more than 30 minutes of time spent on these activities.
14 $97 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$56,191
Total received (2018-2024)
Avg $8,027/year across 7 years
Top 6% in CA for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
605
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$47,126 (83.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,065 (16.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,121
2023
$5,357
2022
$8,405
2021
$7,338
2020
$6,229
2019
$11,277
2018
$12,463

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$3,944
ViiV Healthcare Company
$527
AstraZeneca Pharmaceuticals LP
$120
Paratek Pharmaceuticals, Inc.
$82
Napo Pharmaceuticals Inc
$81
Novo Nordisk Inc
$75
EMD Serono, Inc.
$60
Insmed, Inc.
$48
Merck Sharp & Dohme LLC
$43
ABBVIE INC.
$36
Lilly USA, LLC
$35
GlaxoSmithKline, LLC.
$27
Theratechnologies Inc.
$22
Exact Sciences Corporation
$20
Top 3 companies account for 89.6% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$46,723
ViiV Healthcare Company
$2,567
Merck Sharp & Dohme Corporation
$734
Janssen Biotech, Inc.
$641
Allergan Inc.
$391
Novo Nordisk Inc
$380
EMD Serono, Inc.
$360
Lilly USA, LLC
$339
Janssen Products, LP
$300
CIPLA USA INC.
$292
Napo Pharmaceuticals Inc
$265
AstraZeneca Pharmaceuticals LP
$213
Insmed, Inc.
$208
Janssen Scientific Affairs, LLC
$205
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$178
Paratek Pharmaceuticals, Inc.
$139
PFIZER INC.
$136
Boehringer Ingelheim Pharmaceuticals, Inc.
$131
Allergan, Inc.
$125
Organogenesis Inc.
$125
Melinta Therapeutics, Inc.
$120
Relypsa, Inc.
$115
AbbVie Inc.
$108
Merck Sharp & Dohme LLC
$107
E.R. Squibb & Sons, L.L.C.
$102
Amgen Inc.
$102
Cumberland Pharmaceuticals, Inc.
$95
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$94
Theratechnologies Inc.
$85
Merz North America, Inc.
$82
Amarin Pharma Inc.
$75
Janssen Pharmaceuticals, Inc
$67
SANOFI-AVENTIS U.S. LLC
$65
GlaxoSmithKline, LLC.
$58
Kowa Pharmaceuticals America, Inc.
$57
Theravance Biopharma, Inc.
$46
Medtronic Vascular, Inc.
$42
Smith+Nephew, Inc.
$38
ABBVIE INC.
$36
Antares Pharma, Inc.
$36
Takeda Pharmaceuticals U.S.A., Inc.
$25
Shionogi Inc
$24
Melinta Therapeutics, LLC
$22
Avanir Pharmaceuticals, Inc.
$21
Exact Sciences Corporation
$20
Medtronic, Inc.
$20
Phadia US Inc.
$18
Vyera Pharmaceuticals, LLC
$18
Smith & Nephew, Inc.
$17
VYERA PHARMACEUTICALS, LLC
$15
Nabriva Therapeutics, plc
$12
Sumitomo Pharma America, Inc.
$1
Top 3 companies account for 89.0% of all-time payments
Associated products mentioned in payments ›
APRETUDE · AVYCAZ · Apligraf · Arikayce · BEXSERO · BYSTOLIC · Baxdela · Biktarvy · CABENUVA · CHANTIX · ClosureFast · Cologuard Collection Kit · DALVANCE · DELSTRIGO · DIFICID · DOVATO · Daraprim · Daraprim Tablet 25mg · EGRIFTA · ELIQUIS · EVENITY · FARXIGA · Fetroja · GEMTESA · ISENTRESS · ImmunoCAP · JANUVIA · JARDIANCE · JULUCA · LINZESS · LYRICA · LifeVest · Livalo · MAVYRET · MOUNJARO · Mytesi · NOXAFIL · NUEDEXTA · NUZYRA · OTREXUP · Orbactiv · Otrexup · Ozempic · PIFELTRO · PRALUENT · PREMARIN · PREZCOBIX · PREZISTA · Prolia · RELISTOR · RELISTOR ORAL · SEROSTIM · SHINGRIX · SPIRIVA RESPIMAT · SYMBICORT · SYMTUZA · Santyl · Saxenda · Serostim · Symtuza · TEZSPIRE · TOUJEO · TRADJENTA · TRIUMEQ · TROGARZO · TRULICITY · Tresiba · Trintellix · UBRELVY · VENASEAL · VIBATIV · VIIBRYD · VRAYLAR · Vabomere · Vascepa · Veltassa · Vibativ · Wegovy · XARELTO · XIFAXAN · Xenleta · ZEMDRI (PLAZOMICIN) · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in infectious disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for infectious disease in CA.

Looking for an infectious disease specialist in Fountain Valley?
Compare infectious diseases in the Fountain Valley area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi
129
Per 100K population
4.1
County median income
$113,702
Nearest hospital
UCI HEALTH - FOUNTAIN VALLEY
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lalla-Reddy is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with speaking/promotional industry engagement in the top 6% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lalla-Reddy experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Lalla-Reddy performed 2,508 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lalla-Reddy receive payments from pharmaceutical companies?
Yes. Dr. Lalla-Reddy received a total of $56,191 from 52 companies across 605 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lalla-Reddy's costs compare to other infectious diseases in Fountain Valley?
Dr. Lalla-Reddy's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lalla-Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →